(NCCN) Guidelines® Version 3.2022 for prostate cancer now contains a recommendation for the use of Ga-68 PSMA-11 PET / CT for bone and soft tissue imaging in prostate cancer, as an alternative to imaging.
Isotopia and CPDC Successfully Deliver First Doses of n.c.a. Lu-177 to North American Customers
June 9th, 2022 – Israel and Canada June 9th, 2022 – Israel and Canada Isotopia and CPDC shorten arrival time to patients. The production and